[Polyamines in psoriasis].
D000875:Anthralin / Q000494:pharmacology; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D055598:Chemical Phenomena; D002621:Chemistry; D004311:Double-Blind Method; D000518:Eflornithine; D006801:Humans; D009952:Ornithine / Q000031:analogs & derivatives / Q000494:pharmacology; D065108:Ornithine Decarboxylase Inhibitors; D011701:PUVA Therapy; D011073:Polyamines / Q000096:biosynthesis / Q000378:metabolism*; D011565:Psoriasis / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*
D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; C025025:alpha-methylornithine; D009952:Ornithine; D002262:Carboxy-Lyases; D000875:Anthralin; D000518:Eflornithine
Les polyamines dans le psoriasis.